These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12203767)

  • 1. Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan, (NC100150) for MRI of renal perfusion: experimental study in an animal model.
    Bachmann R; Conrad R; Kreft B; Luzar O; Block W; Flacke S; Pauleit D; Träber F; Gieseke J; Saebo K; Schild H
    J Magn Reson Imaging; 2002 Aug; 16(2):190-5. PubMed ID: 12203767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative renal cortical perfusion in human subjects with magnetic resonance imaging using iron-oxide nanoparticles: influence of T1 shortening.
    Morell A; Ahlstrom H; Schoenberg SO; Abildgaard A; Bock M; Bjørnerud A
    Acta Radiol; 2008 Oct; 49(8):955-62. PubMed ID: 18615336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
    Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
    Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
    Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-pass evaluation of renal perfusion with TurboFLASH MR imaging and superparamagnetic iron oxide particles.
    Trillaud H; Grenier N; Degreze P; Louail C; Chambon C; Franconi JM
    J Magn Reson Imaging; 1993; 3(1):83-91. PubMed ID: 8428106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent.
    Briley-Saebø K; Hustvedt SO; Haldorsen A; Bjørnerud A
    J Magn Reson Imaging; 2004 Oct; 20(4):622-31. PubMed ID: 15390223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
    Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide.
    Krombach GA; Wendland MF; Higgins CB; Saeed M
    Radiology; 2002 Nov; 225(2):479-86. PubMed ID: 12409583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
    Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
    Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
    Bentzen L; Vestergaard-Poulsen P; Nielsen T; Overgaard J; Bjørnerud A; Briley-Saebø K; Horsman MR; Ostergaard L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1208-15. PubMed ID: 15752903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis.
    Schoenberg SO; Aumann S; Just A; Bock M; Knopp MV; Johansson LO; Ahlstrom H
    Magn Reson Med; 2003 Feb; 49(2):288-98. PubMed ID: 12541249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
    Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of renal perfusion using an intravascular contrast agent (part 1): results in a canine model.
    Aumann S; Schoenberg SO; Just A; Briley-Saebo K; Bjørnerud A; Bock M; Brix G
    Magn Reson Med; 2003 Feb; 49(2):276-87. PubMed ID: 12541248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
    Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
    Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical results with Clariscan (NC100150 Injection); experience from different disease models.
    Bjørnerud A; Johansson LO; Ahlström HK
    MAGMA; 2001 May; 12(2-3):99-103. PubMed ID: 11390264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange.
    Bjørnerud A; Johansson LO; Briley-Saebø K; Ahlström HK
    Magn Reson Med; 2002 Mar; 47(3):461-71. PubMed ID: 11870832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.